Louis H. Philipson, MD, PhD, FACP, ADA President, Medicine & Science, is a data-driven scientist with an insatiable desire to ask questions. He’s following in the footsteps of some of his closest friends and “heroes” in the field by focusing on the role of genetics in precision medicine. Read more

The ADA, the American College of Physicians (ACP), The Endocrine Society, and other organizations have all looked at the same science and set different glycemic goals. David D’Alessio, MD, and Timothy J. Wilt, MD, MPH, will debate the merits of the competing guidelines from the ADA and the ACP at 8:00 a.m. Monday in N-Hall... Read more

The artificial pancreas is coming! Medical device makers have been making that promise for 30 years, but this time it appears certain. Timothy S. Bailey, MD, FACE, FACP, CPI, and Jennifer B. Green, MD, MPH, will examine the rapidly evolving landscape of artificial pancreas systems during the Sunday session "On the Road to A... Read more

First results from the CAROLINA outcomes trial comparing linagliptin and glimepiride will be presented at 4:30 p.m. Monday in W-3001 (West, Level 3). Julio Rosenstock, MD, CAROLINA principal investigator, talked to ADAMeetingNews.org about the significance of the trial. Read more

Results from the CREDENCE and CARMELINA clinical trials, both of which targeted patients with type 2 diabetes and chronic kidney disease, will be presented at 7:30 a.m. Tuesday in N-Hall E (North, Exhibition Level). CARMELINA study co-chair Darren K. McGuire, MD, MHSc, discussed the background, objective, and significance o... Read more

Results from the PIONEER Program Trials will be presented at 9:45 a.m. Tuesday in N-Hall E (North, Exhibition Level). ADAMeetingNews.org asked study investigator John B. Buse, MD, PhD, to discuss the significance of the PIONEER studies, which were designed to study the safety and efficacy of an oral formulation of the GLP-1... Read more

The ADA Events app is the best way to stay connected and informed about the 79th Scientific Sessions. Follow these easy steps to download the app to your mobile device, and learn about some of the app’s convenient features to improve your meeting experience. Read more

Before you leave for San Francisco to attend the 79th Scientific Sessions, make sure you’re prepared with these 10 helpful tips. Read more

Here's everything you need to know about getting around San Francisco during the 79th Scientific Sessions. Read more

From traditional American to seafood, Italian, and California-style cuisine, San Francisco has something for everyone. Take your pick with this dining guide. Read more

Gretchen Youssef, MS, RDN, CDE, ADA President, Health Care & Education, has several goals for her year as president. Most of them revolve around improving the lives of patients with diabetes, such as providing better access to diabetes self-management education and support and affordable health care. Read more

Daniel J. Drucker, MD, and Juleen R. Zierath, PhD, will discuss significant basic science and clinical developments in diabetes from the past year during the symposium "Major Advances and Discoveries in Diabetes—The Year in Review" on Monday at the 79th Scientific Sessions. Read more

Diabetes and kidney disease are so closely linked that the ADA and the American Society of Nephrology routinely sponsor a joint symposium that will begin at 8:00 a.m. Sunday in N-Hall E (North, Exhibition Level). This year’s topic is anything but routine, according to Alice Y.Y. Cheng, MD, and Peter Rossing, MD, DMSc. Read more

Results from the Adult Medication Study of the Restoring Insulin Secretion (RISE) clinical trial will be presented at 12:00 p.m. Sunday in S-157 (South, Upper Mezzanine Level). ADAMeetingNews.org asked RISE Consortium co-principal investigator Steven E. Kahn, MB, ChB, to discuss the background, objective, and significance o... Read more

Results from the Dapagliflozin Effect on Cardiovascular Events (DECLARE-TIMI 58) trial will be presented at 2:15 p.m. Sunday in W-3001 (West, Level 3). Itamar Raz, MD, the study’s co-principal investigator, discusses the study's significance. Read more

Results from the Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial will be presented at 4:30 p.m. Sunday in W-3001 (West, Level 3). ADAMeetingNews.org caught up with REWIND study co-chair Hertzel C. Gerstein, MD, MSc, FRCPC, who discusses the study's objective and significance. Read more

Be sure to leave time in your schedule for these special events at the 79th Scientific Sessions. in San Francisco. Read more

Please respect the presenters at the Scientific Sessions by following these photography and social media policies. Read more

The Golden Gate City is full of beautiful sights and sounds. Find time to explore our unique and hilly host city while you’re in town for the 79th Scientific Sessions. Read more

The American Diabetes Association’s 79th Scientific Sessions brings together diabetes professionals from all over the world for five days of comprehensive, unparalleled education through symposia, mini-symposia, oral presentations, poster presentations, professional interest group discussions, and special lectures and addre... Read more

Results from the Vitamin D and Type 2 Diabetes (D2d) Study, a multicenter randomized controlled trial for diabetes prevention, will be presented at 11:30 a.m. Friday in S-157 (South, Upper Level Mezzanine). ADAMeetingNews.org asked the study’s principal investigator, Anastassios G. Pittas, MD, MS, to discuss the background,... Read more

Results from Longitudinal Outcomes in Youth with Type 2 Diabetes—The TODAY2 Study, a post-intervention follow-up to the TODAY Study, will be presented at 1:45 p.m. Saturday in S-154 (South, Upper Mezzanine Level). TODAY2 Study Chair Philip Zeitler, MD, PhD, previews the session and discusses the study's significance. Read more

Results from the PREVention of Diabetes through Lifestyle Intervention and Population Studies in Europe and around the World (PREVIEW) study will be presented at 4:00 p.m. Saturday in S-203 (South, Level 2). ADAMeetingNews.org caught up with PREVIEW study investigator Jennie Brand-Miller, PhD, AM FAA, who discusses the stud... Read more

On Friday, June 7, the Joint ADA/ACC Mini-Symposium—Cardiovascular Disease in Patients with Diabetes will explore the potential synergies of using agents that improve outcomes in patients with diabetes and cardiovascular disease. ADAMeetingNews.org spoke with one of the symposium’s presenters, Sandeep Das, MD, MPH, about ev... Read more

During Sunday's symposium "The Artificial Pancreas in 2019—First Reports of New, Large-Scale Trials and the Path Forward," four researchers will share the latest findings and discuss the potential for regulatory approval of an artificial pancreas system in the near future. Eric Renard, MD, PhD, provides a preview of the ses... Read more

Put the 79th Scientific Sessions in the palm of your hand with the ADA Events Mobile App. Our app delivers the latest meeting updates and makes it easy to search sessions, speakers, abstracts, and exhibitors so you can stay up-to-date with what’s going on at the meeting and make the most of your time in San Francisco. Read more

As part of its commitment to the environment, the ADA is taking a tangible step at the 79th Scientific Sessions to reduce paper consumption. The Scientific Sessions Abstract Book will be available only in a digital format this year, while the official meeting news source has also gone digital at ADAMeetingNews.org. Read more

When the Scientific Sessions convened in San Francisco in 2014, new diabetes research and technology was on the cusp of several breakthroughs. Here are some of the highlights from the 74th Scientific Sessions. Read more